chr16-87696571-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_020655.4(JPH3):c.2167-9C>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00249 in 1,612,372 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0026 ( 11 hom. )
Consequence
JPH3
NM_020655.4 splice_polypyrimidine_tract, intron
NM_020655.4 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0001323
2
Clinical Significance
Conservation
PhyloP100: 1.04
Genes affected
JPH3 (HGNC:14203): (junctophilin 3) Junctional complexes between the plasma membrane and endoplasmic/sarcoplasmic reticulum are a common feature of all excitable cell types and mediate cross talk between cell surface and intracellular ion channels. The protein encoded by this gene is a component of junctional complexes and is composed of a C-terminal hydrophobic segment spanning the endoplasmic/sarcoplasmic reticulum membrane and a remaining cytoplasmic domain that shows specific affinity for the plasma membrane. CAG/CTG repeat expansion from normally 6-28 repeats to 40-59 repeats in the 3' UTR of this gene have been associated with Huntington disease-like 2 (HDL2). This gene is a member of the junctophilin gene family. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 16-87696571-C-G is Benign according to our data. Variant chr16-87696571-C-G is described in ClinVar as [Benign]. Clinvar id is 717235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 287 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
JPH3 | NM_020655.4 | c.2167-9C>G | splice_polypyrimidine_tract_variant, intron_variant | ENST00000284262.3 | |||
JPH3 | NR_073379.3 | n.1881-9C>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
JPH3 | ENST00000284262.3 | c.2167-9C>G | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_020655.4 | P1 | |||
KLHDC4 | ENST00000568444.1 | n.302G>C | non_coding_transcript_exon_variant | 2/2 | 3 | ||||
JPH3 | ENST00000537256.5 | n.1881-9C>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 2 | |||||
JPH3 | ENST00000563609.1 | n.2461-9C>G | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00189 AC: 287AN: 152232Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
287
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00176 AC: 441AN: 250200Hom.: 2 AF XY: 0.00179 AC XY: 242AN XY: 135316
GnomAD3 exomes
AF:
AC:
441
AN:
250200
Hom.:
AF XY:
AC XY:
242
AN XY:
135316
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00255 AC: 3729AN: 1460022Hom.: 11 Cov.: 30 AF XY: 0.00247 AC XY: 1796AN XY: 726434
GnomAD4 exome
AF:
AC:
3729
AN:
1460022
Hom.:
Cov.:
30
AF XY:
AC XY:
1796
AN XY:
726434
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00188 AC: 287AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.00169 AC XY: 126AN XY: 74500
GnomAD4 genome
AF:
AC:
287
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
126
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at